Q2 2017 Anika Therapeutics Earnings Conference Call | Anika Therapeutics, Inc.

Skip to main navigation

About Us
Products
- Overview
- Orthobiologics
  - ORTHOVISC
  - ORTHOVISC MINI
  - MONOVISC
  - CINGAL
  - ORTHOVISC-T
  - HYALOFAST
  - HYALONECT
  - HYALOGLIDE
- Dermal
  - HYALOMATRIX
  - HYALOFILL
  - HYALOGRAN
  - HYALOSAFE
  - ELEVESS
- Surgical
- Other HA Solutions
Technology
Investor Relations
Careers

Search

Investor Relations

Tools

Print
Share

Shareholder Tools

Information Request
Email Alerts
IR Contacts
Virtual Investor Kit
Q4 2017 Fact Sheet
RSS Feeds

Volume:

on

Copyright Nasdaq. Minimum 15 minutes delayed.

Facebook
Google
LinkedIn
Twitter
RSS

Investor Relations

Corporate Overview
Corporate Governance
Stock Information
Analyst Coverage
SEC Filings
Annual Reports and Proxies
Quarterly Results
News Releases
Events & Presentations
Investor FAQs

Q2 2017 Anika Therapeutics Earnings Conference Call

Jul 27, 2017 9:00 AM EDT

Listen to webcast

View Presentation 950.1 KB

© 2018 Anika Therapeutics, Inc. All rights reserved.

Privacy Policy
Site Map
Terms of Use
Forward Looking Statements